Clinical Trials Logo
  1. Home
  2. Atrial Fibrillation New Onset
  3. NCT05927246
  4. Details
NCT05927246 Clinical Trial

Radiotherapy-Associated Atrial Fibrillation

Atrial Fibrillation New Onset Clinical Trial

— RADAF  

Official title:
Radiotherapy-associated Atrial Fibrillation: Onset Time and Frequency

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05927246
Other study ID # COEXIST-1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2023
Est. completion date June 1, 2023

Study information
Verified date June 2023
Source Istanbul University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Radiotherapy associated Atrial Fibrillation (RADAF) is an observational study to evaluate onset time and frequency of atrial fibrillation in patients with thoracic malignancies and breast cancer. Each patient will have 12 lead ECG prior, and daily during radiotherapy.

Description:

Collected data will be truly anonymised and individuals will no longer identifiable, and than evaluated for occurrence of atrial fibrillation. Inclusing Criteria: 1. Patients with radiotherapy for thoracic malignancy or breast cancer 2. Between 18-99 years-old Exclusion Criteria: 1. Patients with history of radiotherapy 2. Patients with history of atrial fibrillation 3. Patients with pacemaker implantation

Recruitment information / eligibility
Status Completed
Enrollment 400
Est. completion date June 1, 2023
Est. primary completion date June 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Patients with radiotherapy for thoracic malignancy or breast cancer - Between 18-99 years-old Exclusion Criteria: - Patients with history of radiotherapy - Patients with history of atrial fibrillation - Patients with pacemaker implantation

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• ECG
12 lead ecg for each participant

Locations
Country Name City State
Turkey Istanbul Faculty of Medicine Fatih Istanbul

Sponsors (1)
Lead Sponsor Collaborator
Istanbul University

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Occurrence of atrial fibrillation Occurrence of atrial fibrillation 1 day During radiotherapy
Primary Onset time of atrial fibrillation Onset time of atrial fibrillation 1 day During radiotherapy
See also
  Status Clinical Trial Phase
Recruiting NCT06055751 - Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
Recruiting NCT04870424 - Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Phase 3
Completed NCT05818592 - Screening for Atrial Fibrillation With Self Pulse Monitoring N/A
Active, not recruiting NCT05780320 - A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
Active, not recruiting NCT03866148 - Obstructive Sleep Apnoea and Cardiac Arrhythmias N/A
Withdrawn NCT05656170 - Stellate Ganglion to Prevent Atrial Fibrillation N/A
Active, not recruiting NCT05255224 - PARADISE: Predicting AF After Cardiac Surgery
Recruiting NCT04528511 - BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
Recruiting NCT04857268 - Diagnostic Validation of Wearable ECG Monitoring Patch, ATP-C120 N/A
Completed NCT04118270 - Shared Decision-Making: AFib 2gether Mobile App N/A
Active, not recruiting NCT03345615 - Standard Versus Intensive Monitoring After Myocardial Infarction Looking for Atrial Fibrillation N/A
Not yet recruiting NCT05841056 - Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial Phase 3
Recruiting NCT06275503 - STROKESTOP III - Optimized Method for Atrial Fibrillation Screening N/A
Recruiting NCT05149820 - Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments Phase 4
Completed NCT03221777 - Atrial Fibrillation Occurring Transiently With Stress (AFOTS)
Not yet recruiting NCT03991754 - Prevention of New Onset AF After TAVI (PAF-TAVI Trial) Phase 3
Completed NCT03118518 - STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation N/A
Completed NCT03552588 - High Sensitivity Estimate of the Incidence of Atrial Fibrillation Occurring Transiently With Stress (AFOTS Incidence Study)
Recruiting NCT05444335 - Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years N/A
Not yet recruiting NCT06458829 - Promoting Atrial Fibrillation Screening in Primary Care N/A